Regulus Therapeutics
RGLS
#8387
Rank
C$0.14 B
Marketcap
$2.20
Share price
1.25%
Change (1 day)
-0.36%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$8.05 M

According to Regulus Therapeutics's latest financial reports the company's total liabilities are C$8.05 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$18.21 M6.66%
2021-12-31C$17.08 M15.68%
2020-12-31C$14.76 M-48.39%
2019-12-31C$28.6 M-37.93%
2018-12-31C$46.08 M-13.94%
2017-12-31C$53.55 M-10.63%
2016-12-31C$59.91 M153.73%
2015-12-31C$23.61 M-48.41%
2014-12-31C$45.77 M45.32%
2013-12-31C$31.49 M-23.71%
2012-12-31C$41.28 M-51.9%
2011-12-31C$85.82 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$76.01 B 943,744.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$82.52 B 1,024,549.71%๐Ÿ‡ซ๐Ÿ‡ท France
C$14.80 B 183,716.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$87.81 B 1,090,199.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$5.44 B 67,476.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$94.03 M 1,067.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$105.22 B 1,306,349.98%๐Ÿ‡บ๐Ÿ‡ธ USA